GenDx is celebrating 20 years of innovation and excellence in transplant diagnostics
This year, GenDx celebrates 20 years and two decades of dedication to transplant diagnostics. What started as a small team of scientists with a shared vision has grown into a globally recognized leader, driven by innovation, collaboration, and a commitment to improving the quality of life and survival of transplant patients.
The beginning
On January 1st, 2004, Erik Rozemuller and Wietse Mulder began shaping Genome Diagnostics. After a year of planning, GenDx was officially established on March 1st, 2005. They started as a small team of dedicated scientists working to develop better tools for high-resolution HLA typing. From the beginning, collaboration and education were as important as innovation. GenDx knew that true progress in transplantation wouldn’t come from technology alone but also from sharing knowledge with the healthcare professionals who rely on it every day.
Growing with purpose
Over the years, GenDx has evolved, but their core mission has remained the same. In 2013, they introduced NGSgo reagents and NGSengine software, making high-resolution sequencing for HLA typing more accessible to labs worldwide. As their expertise grew, GenDx expanded the focus to include chimerism monitoring with NGStrack and TRKengine, helping transplant teams detect complications earlier.
In 2022, they became part of Eurobio Scientific, a step that allowed us to strengthen our impact globally while remaining true to their values. Today, GenDx is proud to be part of a broader network of diagnostics specialists, with affiliates across Europe and other parts of the world.
A global leader in transplant diagnostics
GenDx is one of the top tier companies in transplant diagnostics worldwide, recognized for their commitment to research, education, and high-quality solutions. GenDx has grown into a team of over 110 colleagues from 20 different nationalities, bringing diverse perspectives and expertise to its work. This would not be possible without the support and commitment from their customers and partners.
Olympic champion Maarten van der Weijden swims one last time, now for the Máxima
Maarten van der Weijden is putting on his swimming suit one last time to raise money for cancer research. From 17 to 22 August, he will swim an incredible 270 kilometers through 22 cities, with the Princess Máxima Center as his final destination. With this special challenge, he is raising money for pioneering research into the immediate and long-term effects of childhood cancer.
New exit for construction traffic at the Utrecht Science Park
Various construction works are taking place in the north-west cluster of Utrecht Science Park. This is the area where the Minnaert Building and the Buys Ballot Building, amongst others, are located. To ensure that construction traffic flows more safely and efficiently through the area, a new exit is being constructed from Sorbonnelaan to Leuvenlaan.
Eliminating cancer with light
Killing tumors with light. Is that something for the distant future? Certainly not! UMC Utrecht and start-up Lumox are now going to test an innovative therapy in a first patient study.
Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals
On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).